• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

周期性缺氧的出现及 PARP 抑制剂对肿瘤进展的影响。

Emergence of cyclic hypoxia and the impact of PARP inhibitors on tumor progression.

机构信息

Department of Mathematical, Physical and Computer Sciences, University of Parma, Parco Area delle Scienze 53/A, 43124, Parma, Italy.

Division of Mathematical Oncology and Computational Systems Biology Department of Computational and Quantitative Medicine, Beckman Research Institute City of Hope National Medical Center, 1500 E Duarte Rd., Duarte, 91010, CA, USA.

出版信息

NPJ Syst Biol Appl. 2024 Oct 22;10(1):122. doi: 10.1038/s41540-024-00453-2.

DOI:10.1038/s41540-024-00453-2
PMID:39433780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11494044/
Abstract

Tumor hypoxia is a dynamic phenomenon marked by fluctuations in oxygen levels across both rapid (seconds to minutes) and slow (hours to days) time scales. While short hypoxia cycles are relatively well understood, the mechanisms behind longer cycles remain largely unclear. In this paper, we present a novel mechanistic mathematical model that explains slow hypoxia cycles through feedback loops involving vascular expansion and regression, oxygen-regulated tumor growth, and toxic cytokine production. Our study reveals that, for the emergence of slow hypoxia cycles, endothelial cells must adapt by decreasing receptor activation as ligand concentration increases. Additionally, the interaction between tumor cells and toxic cytokines influences frequency and intensity of these cycles. By examining the effects of pharmacological interventions, specifically poly (ADP-ribose) polymerase inhibitors, we also demonstrate how targeting cell proliferation can help regulate oxygen levels. Our findings enhance the understanding of hypoxia regulation and suggest PARP proteins as promising therapeutic targets.

摘要

肿瘤缺氧是一种动态现象,其特征是氧水平在快速(秒到分钟)和缓慢(小时到天)时间尺度上波动。虽然短时间缺氧循环相对较好理解,但长时间缺氧循环背后的机制在很大程度上仍不清楚。在本文中,我们提出了一个新的机制数学模型,该模型通过涉及血管扩张和收缩、氧调节肿瘤生长和毒性细胞因子产生的反馈回路来解释缓慢缺氧循环。我们的研究表明,对于缓慢缺氧循环的出现,内皮细胞必须通过随着配体浓度的增加而减少受体激活来适应。此外,肿瘤细胞和毒性细胞因子之间的相互作用影响这些循环的频率和强度。通过检查药理学干预(特别是聚(ADP-核糖)聚合酶抑制剂)的效果,我们还证明了靶向细胞增殖如何有助于调节氧水平。我们的发现增强了对缺氧调节的理解,并表明 PARP 蛋白是有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/32fb1e443635/41540_2024_453_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/acbda2735eca/41540_2024_453_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/e1f408367f19/41540_2024_453_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/5c275364c237/41540_2024_453_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/2fbb7e224564/41540_2024_453_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/f80cfd60d7a1/41540_2024_453_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/52ca58bb9078/41540_2024_453_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/b1a1a0b34853/41540_2024_453_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/32fb1e443635/41540_2024_453_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/acbda2735eca/41540_2024_453_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/e1f408367f19/41540_2024_453_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/5c275364c237/41540_2024_453_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/2fbb7e224564/41540_2024_453_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/f80cfd60d7a1/41540_2024_453_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/52ca58bb9078/41540_2024_453_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/b1a1a0b34853/41540_2024_453_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f82a/11494044/32fb1e443635/41540_2024_453_Fig8_HTML.jpg

相似文献

1
Emergence of cyclic hypoxia and the impact of PARP inhibitors on tumor progression.周期性缺氧的出现及 PARP 抑制剂对肿瘤进展的影响。
NPJ Syst Biol Appl. 2024 Oct 22;10(1):122. doi: 10.1038/s41540-024-00453-2.
2
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.聚(ADP-核糖)聚合酶(PARP)和 PARP 抑制剂:作用机制及在心血管疾病中的作用。
Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.
3
PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice.聚(ADP-核糖)聚合酶(PARP)在人类哮喘中被激活,而奥拉帕尼对其的抑制作用可阻断小鼠中屋尘螨诱发的疾病。
Clin Sci (Lond). 2015 Dec;129(11):951-62. doi: 10.1042/CS20150122. Epub 2015 Jul 23.
4
Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.选择性靶向 PARP-2 通过破坏 FOXA1 功能抑制雄激素受体信号和前列腺癌生长。
Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14573-14582. doi: 10.1073/pnas.1908547116. Epub 2019 Jul 2.
5
Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics.聚(ADP-核糖)聚合酶(PARPs)和 PARP 抑制剂靶向治疗药物。
Anticancer Agents Med Chem. 2019;19(2):206-212. doi: 10.2174/1871520618666181109164645.
6
Discovery of Novel Dual Poly(ADP-ribose)polymerase and Phosphoinositide 3-Kinase Inhibitors as a Promising Strategy for Cancer Therapy.发现新型双聚(ADP-核糖)聚合酶和磷酸肌醇 3-激酶抑制剂,为癌症治疗提供新策略。
J Med Chem. 2020 Jan 9;63(1):122-139. doi: 10.1021/acs.jmedchem.9b00622. Epub 2019 Dec 27.
7
Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment.聚(ADP - 核糖)聚合酶抑制在卵巢癌治疗中的研究进展
J Transl Med. 2016 Sep 15;14:267. doi: 10.1186/s12967-016-1027-1.
8
LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation.低密度脂蛋白受体相关蛋白1通过抑制聚(ADP-核糖)聚合酶-1活性和内皮细胞增殖来调节视网膜血管生成。
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):350-60. doi: 10.1161/ATVBAHA.115.306713. Epub 2015 Dec 3.
9
Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.聚(ADP-核糖)聚合酶抑制剂激活神经干/祖细胞中的p53信号通路。
BMC Neurosci. 2017 Jan 17;18(1):14. doi: 10.1186/s12868-016-0333-0.
10
Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells.三阴性乳腺癌中聚(ADP-核糖)聚合酶(PARP)和组蛋白去乙酰化酶(HDAC)的联合靶向治疗:BRCA 突变细胞中更高的协同作用。
Biomed Pharmacother. 2018 Mar;99:543-551. doi: 10.1016/j.biopha.2018.01.045. Epub 2018 Feb 20.

引用本文的文献

1
Synthetic Lethality-Based Targets and Their Exploration in Tumour Combination Strategies.基于合成致死性的靶点及其在肿瘤联合治疗策略中的探索
J Cell Mol Med. 2025 Aug;29(16):e70756. doi: 10.1111/jcmm.70756.

本文引用的文献

1
Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation.长时间缺氧可减轻脯氨酰羟化酶介导的 RIPK1 抑制作用,促进坏死性凋亡和炎症反应。
Nat Cell Biol. 2023 Jul;25(7):950-962. doi: 10.1038/s41556-023-01170-4. Epub 2023 Jul 3.
2
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions.缺氧微环境与癌症:分子机制与治疗干预。
Signal Transduct Target Ther. 2023 Feb 17;8(1):70. doi: 10.1038/s41392-023-01332-8.
3
PARP inhibition promotes endothelial-like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry.
PARP 抑制剂促进黑色素瘤细胞呈现内皮样特征,并调节血管生成拟态过程中的周细胞覆盖动力学。
J Pathol. 2023 Mar;259(3):318-330. doi: 10.1002/path.6043. Epub 2023 Jan 4.
4
BNIP3 and Nix: Atypical regulators of cell fate.BNIP3 和 Nix:细胞命运的非典型调节因子。
Biochim Biophys Acta Mol Cell Res. 2022 Oct;1869(10):119325. doi: 10.1016/j.bbamcr.2022.119325. Epub 2022 Jul 19.
5
Structural Features of Microvascular Networks Trigger Blood Flow Oscillations.微血管网络的结构特征引发血流振荡。
Bull Math Biol. 2022 Jul 8;84(8):85. doi: 10.1007/s11538-022-01046-y.
6
A DNA-structured mathematical model of cell-cycle progression in cyclic hypoxia.周期性低氧条件下细胞周期进展的 DNA 结构数学模型。
J Theor Biol. 2022 Jul 21;545:111104. doi: 10.1016/j.jtbi.2022.111104. Epub 2022 Mar 23.
7
Selective modulation by PARP-1 of HIF-1α-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions.PARP-1对缺氧时HIF-1α募集至染色质的选择性调节是肿瘤适应缺氧条件所必需的。
Redox Biol. 2021 May;41:101885. doi: 10.1016/j.redox.2021.101885. Epub 2021 Feb 1.
8
Cyclic Hypoxia: An Update on Its Characteristics, Methods to Measure It and Biological Implications in Cancer.循环性缺氧:其特征、测量方法及在癌症中的生物学意义的最新进展
Cancers (Basel). 2020 Dec 23;13(1):23. doi: 10.3390/cancers13010023.
9
Cellular adaptation to hypoxia through hypoxia inducible factors and beyond.细胞通过缺氧诱导因子及其以外的方式适应缺氧。
Nat Rev Mol Cell Biol. 2020 May;21(5):268-283. doi: 10.1038/s41580-020-0227-y. Epub 2020 Mar 6.
10
Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression.急慢性与周期性缺氧:它们的动态差异、分子机制,以及对肿瘤进展的影响。
Biomolecules. 2019 Aug 3;9(8):339. doi: 10.3390/biom9080339.